Case File №
#VI-2026-0415
Quenna PMQ
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
39 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | D Poor | 7 | 6.9 | 3.6 | 9.7 | 5 Oct 2025 |
| Tirzepatide | D Poor | 8 | 6.3 | 3.7 | 9.0 | 16 Jul 2025 |
| 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | X N/A | 1 | 6.8 | 6.8 | 6.8 | 21 May 2025 |
| Arimidex (Anastrozole) | X N/A | 1 | 9.1 | 9.1 | 9.1 | 8 Jul 2025 |
| BAM15 | X N/A | 1 | 10.0 | 10.0 | 10.0 | 13 Jun 2025 |
| BMK ethyl glycidate CAS 41232-97-7 | X N/A | 1 | 6.6 | 6.6 | 6.6 | 16 Mar 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 5.4 | 5.4 | 5.4 | 7 May 2025 |
| Cardiogen | X N/A | 1 | 5.1 | 5.1 | 5.1 | 13 Jun 2025 |
| CJC-1295 With DAC | X N/A | 1 | 7.0 | 7.0 | 7.0 | 7 May 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 7.6 | 7.6 | 7.6 | 2 Jul 2025 |
| Cortagen | X N/A | 1 | 5.1 | 5.1 | 5.1 | 13 Feb 2025 |
| Dapoxetine | X N/A | 1 | 7.0 | 7.0 | 7.0 | 6 May 2025 |
| EPO | X N/A | 1 | 5.7 | 5.7 | 5.7 | 25 Apr 2025 |
| GHRP-2 Acetate | X N/A | 1 | 6.4 | 6.4 | 6.4 | 3 Jul 2025 |
| Glutathione | X N/A | 1 | 5.5 | 5.5 | 5.5 | 7 May 2025 |
| IGF-1 LR3 | X N/A | 1 | 6.3 | 6.3 | 6.3 | 16 Mar 2025 |
| Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | X N/A | 1 | 5.5 | 5.5 | 5.5 | 17 Dec 2024 |
| Isotretinoin | X N/A | 1 | 5.0 | 5.0 | 5.0 | 13 Feb 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 7.6 | 7.6 | 7.6 | 16 Mar 2025 |
| Livagen | X N/A | 1 | 7.1 | 7.1 | 7.1 | 28 Mar 2025 |
| MT-1 | X N/A | 1 | 4.4 | 4.4 | 4.4 | 13 Feb 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 5.4 | 5.4 | 5.4 | 28 Mar 2025 |
| Nitroethane CAS 79-24-3 | X N/A | 1 | 7.8 | 7.8 | 7.8 | 14 Jan 2025 |
| Orforglipron | X N/A | 1 | 6.3 | 6.3 | 6.3 | 28 Mar 2025 |
| Ostarine (MK-2866) | X N/A | 1 | 7.3 | 7.3 | 7.3 | 6 May 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 7.6 | 7.6 | 7.6 | 14 Jan 2025 |
| Salbutamol | X N/A | 1 | 6.0 | 6.0 | 6.0 | 13 Feb 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 7.3 | 7.3 | 7.3 | 27 Feb 2025 |
| T3 (Liothyronine) | X N/A | 1 | 4.3 | 4.3 | 4.3 | 2 Jul 2025 |
| Tadalafil (Cialis) | X N/A | 1 | 4.0 | 4.0 | 4.0 | 17 Dec 2024 |
| Tamoxifen (Nolvadex) Raw | X N/A | 1 | 5.6 | 5.6 | 5.6 | 25 Apr 2025 |
| Test Enanthate | X N/A | 1 | 7.9 | 7.9 | 7.9 | 2 Apr 2025 |
| Testosterone Decanoate Raw | X N/A | 1 | 7.7 | 7.7 | 7.7 | 16 Mar 2025 |
| Thymalin | X N/A | 1 | 5.9 | 5.9 | 5.9 | 2 Apr 2025 |
| Tirzepatide Oral | X N/A | 1 | 5.8 | 5.8 | 5.8 | 24 Apr 2025 |
| Tren Base | X N/A | 1 | 6.0 | 6.0 | 6.0 | 17 Dec 2024 |
| TrenMix 200 | X N/A | 1 | 7.6 | 7.6 | 7.6 | 24 Apr 2025 |
| Vilon | X N/A | 1 | 7.3 | 7.3 | 7.3 | 24 Apr 2025 |
| Vitamin B12 1mg/ml | X N/A | 1 | 8.1 | 8.1 | 8.1 | 21 May 2025 |
Exhibit II
Evidence Log
44 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | BMK ethyl glycidate CAS 41232-97-7 | 5.3 B | 5g | 5.0g | -1.0% | 98.00% | f2x1bp | Lab A | Community |
| 24 May 2026 | Dapoxetine | 9.6 A | 100mg | 101.9mg | +1.9% | 96.95% | wnlt2s | Lab C | Public |
| 24 May 2026 | N-Acetyl Epitalon Amidate | 4.9 C | 2mg | 1.8mg | -10.5% | 96.31% | 96ona9 | Lab F | Public |
| 23 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 7.3 A | 30mg | 33.7mg | +12.5% | 95.52% | nhuts3 | Lab C | Public |
| 23 May 2026 | Salbutamol | 7.0 A | 25mg | 23.1mg | -7.4% | 96.33% | 3zv40o | Lab D | Public |
| 23 May 2026 | 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | 6.6 A | 5g | 5.5g | +10.2% | 99.91% | p4x7av | Lab A | Public |
| 23 May 2026 | Thymalin | 6.2 A | 50mg | 49.5mg | -1.1% | 97.09% | zkibs6 | Lab A | Community |
| 21 May 2026 | Tirzepatide | 3.7 E | 10mg | 11.2mg | +12.0% | 98.68% | n/a | No Label / Silver Crimp / White Cap | Lab E |
| 21 May 2026 | Nitroethane CAS 79-24-3 | 7.7 A | 1g | 1.1g | +8.5% | 96.58% | hzxaa6 | Lab G | Public |
| 19 May 2026 | Isotretinoin | 5.2 B | 25mg | 24.6mg | -1.7% | 98.29% | cvznpl | Lab E | Public |
| 19 May 2026 | MT-1 | 4.0 C | 20mg | 21.6mg | +8.0% | 98.68% | xk96ag | Lab B | Community |
| 17 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.2 A | 20mg | 19.5mg | -2.5% | 95.45% | kf4e6s | Lab E | Community |
| 17 May 2026 | GHRP-2 Acetate | 4.3 C | 2mg | 1.8mg | -9.2% | 98.45% | ot6eio | Lab G | Public |
| 17 May 2026 | Vilon | 6.5 A | 5mg | 5.7mg | +14.3% | 95.68% | po9r7f | Lab C | Public |
| 26 Jan 2026 | Tirzepatide | 5.0 C | 30mg | 35.4mg | +18.0% | 99.80% | n/a | No Label / Copper Crimp / Clear Cap | Lab G |
| 26 Jan 2026 | CJC-1295 With DAC | 5.7 B | 20mg | 24.6mg | +23.0% | 96.84% | ixzpw0 | Lab C | Public |
| 26 Jan 2026 | Selank 10mg + Semax 10mg Blend | 8.9 A | 5mg | 5.5mg | +10.6% | 98.70% | 9xidv5 | Lab B | Public |
| 9 Jan 2026 | Cortagen | 4.2 C | 2mg | 2.3mg | +13.9% | 97.78% | snk49q | Lab G | Public |
| 7 Jan 2026 | T3 (Liothyronine) | 4.0 C | 25mg | 22.6mg | -9.4% | 95.67% | ukgdqv | Lab G | Community |
| 6 Jan 2026 | Livagen | 6.8 A | 20mg | 20.3mg | +1.6% | 99.05% | utrhei | Lab G | Community |
| 6 Jan 2026 | Tadalafil (Cialis) | 4.0 C | 20mg | 22.0mg | +10.0% | 95.71% | oxmg0i | Lab B | Public |
| 6 Jan 2026 | Vitamin B12 1mg/ml | 9.9 A | 300mg/ml | 364.7mg/ml | +21.6% | 97.85% | dbfx4j | Lab F | Public |
| 1 Jan 2026 | Retatrutide | 6.3 B | 10mg | 10.9mg | +9.0% | 99.70% | n/a | (no data) | Lab G |
| 29 Dec 2025 | Retatrutide | 9.7 A | 10mg | 10.6mg | +6.0% | 99.91% | low | White Label / Silver Crimp / Clear Blue Cap | Lab E |
| 29 Dec 2025 | EPO | 4.9 C | 30mg | 25.7mg | -14.2% | 98.03% | g7ry9n | Lab F | Public |
| 29 Dec 2025 | TrenMix 200 | 7.9 A | 100mg/ml | 114.3mg/ml | +14.3% | 95.36% | 2osyln | Lab E | Public |
| 13 Dec 2025 | Tirzepatide | 4.7 D | 60mg | 67.8mg | +13.0% | 99.40% | n/a | No Label / Copper Crimp / Clear Cap | Lab G |
| 13 Dec 2025 | Retatrutide | 6.8 B | 20mg | 21.4mg | +7.0% | 99.70% | n/a | No Label / Copper Crimp / Clear Cap | Lab G |
| 5 Dec 2025 | BAM15 | 10.0 A | 100mg | 120.2mg | +20.2% | 95.98% | 9m8c50 | Lab A | Public |
| 5 Dec 2025 | Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | 5.0 B | 250mg/ml | 225.6mg/ml | -9.7% | 99.82% | 7uq356 | Lab F | Community |
| 23 Nov 2025 | Tirzepatide Oral | 6.0 A | 100mg | 118.5mg | +18.5% | 96.81% | zbgdor | Lab D | Community |
| 17 Nov 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 4.0 C | 10mg | 12.2mg | +21.5% | 98.18% | qytimq | Lab C | Public |
| 17 Nov 2025 | Tren Base | 5.7 B | 200mg/ml | 179.6mg/ml | -10.2% | 95.19% | q05kb0 | Lab A | Community |
| 5 Nov 2025 | Cardiogen | 4.9 C | 5mg | 5.2mg | +4.3% | 96.96% | 6vyfo7 | Lab C | Public |
| 5 Nov 2025 | IGF-1 LR3 | 5.4 B | 30mg | 27.8mg | -7.4% | 96.39% | iavvu8 | Lab G | Community |
| 17 Oct 2025 | Orforglipron | 8.7 A | 25mg | 29.5mg | +18.1% | 97.00% | mm9axi | Lab F | Public |
| 17 Oct 2025 | Testosterone Decanoate Raw | 9.1 A | 1g | 1.2g | +15.0% | 95.22% | n8j3jd | Lab G | Public |
| 9 Oct 2025 | Arimidex (Anastrozole) | 10.0 A | 20mg | 21.9mg | +9.3% | 97.98% | cedh0t | Lab C | Public |
| 9 Oct 2025 | Glutathione | 5.7 B | 30mg | 30.7mg | +2.5% | 99.91% | lgn9ff | Lab B | Public |
| 9 Oct 2025 | Ostarine (MK-2866) | 7.6 A | 100mg | 104.1mg | +4.1% | 98.38% | c5edqm | Lab F | Public |
| 9 Oct 2025 | Tamoxifen (Nolvadex) Raw | 5.3 B | 100g | 102.2g | +2.2% | 95.43% | 91zwd2 | Lab G | Community |
| 9 Oct 2025 | Test Enanthate | 6.7 A | 100mg/ml | 121.8mg/ml | +21.8% | 95.22% | knvn2u | Lab D | Community |
| 3 Oct 2025 | Retatrutide 30mg Pen Kit | 8.3 A | 50mg | 57.1mg | +14.3% | 95.83% | a2vef7 | Lab A | Public |
| 6 Dec 2025⚠️ | Tirzepatide | 8.0 A | 30mg | 31.1mg | +3.7% | 99.95% | n/a | No Label / Silver Crimp / Clear Teal Cap | Lab E |
— END OF EVIDENCE LOG —